Results 251 to 260 of about 396,771 (306)

Clinical Manifestations and Risk Factors of Osteoporosis in Patients with Type 2 Diabetes Mellitus. [PDF]

J Inflamm Res
Wang Y, Du Y, Zuo J, He L, Shi Y, Yuan Y, Liu Y, Zheng H, Wang H.   +8 more
europepmc   +1 more source

High-density lipoprotein-related inflammatory ratios and coronary heart disease: A cross-sectional machine learning analysis of NHANES 2009 to 2020. [PDF]

Medicine (Baltimore)
Cai Y, Zhang G.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants

Current Opinion in Lipidology, 2019
Purpose of review The validity of HDL-cholesterol (HDL-C) elevation as a therapeutic target has been questioned, in comparison to enhancing HDL functionality. Cholesterol efflux capacity (CEC) is an in-vitro assay that measures the ability of an individual's HDL to promote cholesterol efflux from cholesterol donor cells such as
David, Rhainds, Jean-Claude, Tardif
openaire   +2 more sources

Serum cholesterol and HDL cholesterol in childhood

Irish Journal of Medical Science, 1981
Serum concentrations of total cholesterol and of HDL cholesterol have been measured in 170 Irish children, aged 1–12 years, attending hospital for conditions other than hyperlipidaemia. There were no significant differences between the sexes, or between fasting and non-fasting samples for either estimation.
D A, Kelly, H, Hooey, G, Neale, A R, McGill, M, Stuart   +4 more
openaire   +2 more sources

Cholesterol, High Density Lipoprotein‐Cholesterol (HDL) and Cholesterol/HDL‐ratio Versus Arterial Blood Pressure.

Acta Medica Scandinavica, 1981
Abstract: In a cardiovascular survey of 928 men and women aged exactly 30, 40, 50 & 60 years, a correlation between serum cholesterol, cholesterol/HDL‐ratio and arterial blood pressure was found. This correlation was indirectly caused by mutual correlations to relative weight and age as a final result found after multiple rank correlation analysis
E, Agner, H I, Mørck, T, Brendstrup, H, Hollnagel, M, Schroll, F, Gyntelberg   +5 more
openaire   +2 more sources

Increasing HDL Cholesterol Levels

New England Journal of Medicine, 2004
In the past decade, high-density lipoproteins (HDL) have emerged as a new potential therapeutic target for the treatment of cardiovascular disease. The key role of HDL as a carrier of excess cellular cholesterol in the reverse cholesterol transport pathway is believed to provide protection against atherosclerosis.
openaire   +2 more sources

Thiazolidinediones and Lowered HDL Cholesterol

Diabetes Care, 2005
Three publications, including two recently in Diabetes Care, have indicated that a combination of rosiglitazone and fibrates may lower serum HDL cholesterol in some patients (1–3). It is known that a paradoxical fall in HDL cholesterol may occur with fibrates.
Ruth L, Savage, Anne, Kiuru
openaire   +2 more sources

HDL cholesterol transport during inflammation

Current Opinion in Lipidology, 2007
The aim of this article is to review recent advances made towards understanding how inflammation and acute phase proteins, particularly serum amyloid A and group IIa secretory phospholipase A2, may alter reverse cholesterol transport by HDL during inflammation and the acute phase response.Findings suggest that the decreased apoA-I content and markedly ...
Deneys R, van der Westhuyzen, Frederick C, de Beer, Nancy R, Webb   +2 more
openaire   +2 more sources